Kurz gefasst
Kommentar in der Zeitschrift Immunity, 2026. Verfasst von Abishek Vaidya und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and Immunotherapy and Marc and Jennifer Lipschultz Precision Immunology Institute, ISMMS, New York, NY, USA; Graduate School…. Hauptthemen laut MEDLINE: CD4-Positive T-Lymphocytes, T-Box Domain Proteins. Die Arbeit nennt 10 Literaturangaben. Gefördert von: National Institutes of Health, National Cancer Institute.
Abstract (Originalsprache)
Similar to CD8+ T cells, stem-like CD4+ T cells sustain responses to tumors, chronic infections, and inflammation. In this issue of Immunity, Wen et al. and Agesta et al. reveal EOMES as a critical regulator of stem-like CD4+ T cell maintenance and differentiation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Immunology and Immunotherapy and Marc and Jennifer Lipschultz Precision Immunology Institute, ISMMS, New York, NY, USA; Graduate School of Biomedical Sciences, ISMMS, New York, NY, USA.
- Department of Immunology and Immunotherapy and Marc and Jennifer Lipschultz Precision Immunology Institute, ISMMS, New York, NY, USA; Graduate School of Biomedical Sciences, ISMMS, New York, NY, USA; Department of Oncol…
Förderung
- National Institutes of Health
- National Cancer Institute
Zitieren
APA
Vaidya, A., & Kamphorst, A. O. (2026). CD4+ T cells persist with their Eomes. Immunity. https://doi.org/10.1016/j.immuni.2026.06.017
Vancouver
Vaidya A, Kamphorst AO. CD4+ T cells persist with their Eomes. Immunity. 2026. doi:10.1016/j.immuni.2026.06.017
BibTeX
@article{Vaidya2026,
author = {Vaidya, Abishek and Kamphorst, Alice O},
title = {CD4+ T cells persist with their Eomes},
journal = {Immunity},
year = {2026},
doi = {10.1016/j.immuni.2026.06.017}
}
EUVIMED